Owners
Medidata Solutions is an American clinical trial software developer founded in 1999. The company's solutions allow you to collect patient data from online platforms, mobile medical devices, imaging systems, and laboratory reports. In addition, the software can manage the quality of research through artificial intelligence technologies, monitor medical processes and conduct business analysis.
History
2019: Dassault Systemes bought Medidata for $5.8 billion
On June 13, 2019, Dassault Systemes announced the acquisition of Medidata Solutions for $5.8 billion. The value of the transaction, which is scheduled to close in the fourth quarter, in terms of one share of the company being sold, is $92.25, which is slightly lower than the securities exchange rate by June 11.
By absorbing Medidata Solutions, Dassault Systemes will be able to diversify its biomedical business by providing customers with a full-cycle platform for research and development, clinical trials, and the production and commercialization of new products and technologies.
 | Multidisciplinary scientific innovations and productivity in the industrial sector require a platform approach that connects people, ideas and data, "said Dassault CEO Bernard Charles. |  |
The deal with Medidata Solutions was the largest acquisition for Dassault. To pay for it, the company will take a loan of 4 billion euros.
By the beginning of June 2019, Medidata Solutions has about 1.3 thousand customers, among which are the largest pharmaceutical companies. The market capitalization of Medidata Solutions by June 13, 2019 amounted to $5.9 billion, and the Dassault indicator - $41 billion.
According to analysts at Invest Securities, the cost of buying Medidata Solutions surprised investors. Roche Brune Asset Management stock manager Gregoire Laverne considers the deal a positive step, especially since Dassault, according to the expert, has enough financial resources.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |